Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc. > CLASS IS BACK IN SESSION: HERE'S A HINT TO THE LAST QUESTION

<< Previous

Bullboard Posts

Next >>

Comment by Arbourmarkon Apr 13, 2021 6:31pm

144 Views

Post# 32989963

RE:CLASS IS BACK IN SESSION: HERE'S A HINT TO THE LAST QUESTION

A leopard can't change its spots!

BitHorse wrote:

Q: Anybody wanna take a guess about how the story played itself out?

Hint

1) https://www.accesswire.com/438746/Miraculins-Announces-Name-Change-New-Stock-Symbol-and-Share-Consolidation

2) https://www.bloomberg.com/press-releases/2018-03-09/luminor-medical-technologies-changes-its-name-to-rise-life-science-corp

3) https://riselifescience.com/investors/

BH